Drug Patent Watch
MARCH 31, 2024
A recent study published in JAMA Health Forum sheds light on the impact of biosimilar competition on patient out-of-pocket (OOP) costs for biologic drugs in the United States.
Cloudbyz
MARCH 31, 2024
The landscape of clinical trial management is undergoing a significant transformation, driven by the complex demands of modern medical research. At the heart of this change is a move away from traditional point systems—discrete tools designed for specific tasks within a trial—to comprehensive platform solutions that offer a unified approach to managing all aspects of a trial.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
MARCH 31, 2024
Annual Drug Patent Expirations for IONSYS Ionsys is a drug marketed by The Medicines Co and is included in one NDA. There are eight patents protecting this drug.
JAMA Internal Medicine
MARCH 31, 2024
This cross-sectional study assesses the ability of a large language model to process medical data and display clinical reasoning compared with the ability of attending physicians and residents.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Law Blog
MARCH 31, 2024
By Ana Loloei & Jeffrey N. Gibbs — On March 21, 2024, the House Energy and Commerce held a subcommittee hearing titled “Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule.” House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee Chair Brett Guthrie (R-KY), in announcing the hearing, made their views clear: “FDA has proposed a rule that relies upon dubious and misguided legal, economic, and public health arguments and
Trialfacts
MARCH 31, 2024
Contents About the Study Why Participate? Your Rights Who Can Participate? More Study Details About the Research Center Study Location Research Center: National Jewish Health Location: 1400 Jackson Street, Denver, Colorado 80206 Lead Researcher: Donald Y M Leung, Ph.D., MD IRB: This study has been reviewed and approved by the BRANY (Biomedical Research Alliance of New York) Institutional Review Board About the Study Approximately 1 in 10 individuals suffer from atopic dermatitis (AD), a chronic
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
JAMA Internal Medicine
MARCH 31, 2024
This case report describes a patient in their 70s presenting to the hospital with dyspnea and fatigue.
Drug Patent Watch
MARCH 31, 2024
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.
JAMA Internal Medicine
MARCH 31, 2024
This interrupted time series analysis assesses the association of reduced hours of alcohol sales at bars/taverns with violent crime rates in Baltimore.
Expert insights. Personalized for you.
105 
Let's personalize your content